S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Stock market today: Wall Street rises in premarket as bond markets stabilize and earnings roll in
Abbott Laboratories Outlook is Healthy: Buy the Dip
Predicting a Bear Market: 7 Signs and Why it's Tough to Do
Closing prices for crude oil, gold and other commodities
United Airlines Soars on Earnings Beat
CSX profit drops 10% despite railroad delivering 3% more freight in first quarter
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Stock market today: Wall Street rises in premarket as bond markets stabilize and earnings roll in
Abbott Laboratories Outlook is Healthy: Buy the Dip
Predicting a Bear Market: 7 Signs and Why it's Tough to Do
Closing prices for crude oil, gold and other commodities
United Airlines Soars on Earnings Beat
CSX profit drops 10% despite railroad delivering 3% more freight in first quarter
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Stock market today: Wall Street rises in premarket as bond markets stabilize and earnings roll in
Abbott Laboratories Outlook is Healthy: Buy the Dip
Predicting a Bear Market: 7 Signs and Why it's Tough to Do
Closing prices for crude oil, gold and other commodities
United Airlines Soars on Earnings Beat
CSX profit drops 10% despite railroad delivering 3% more freight in first quarter
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Stock market today: Wall Street rises in premarket as bond markets stabilize and earnings roll in
Abbott Laboratories Outlook is Healthy: Buy the Dip
Predicting a Bear Market: 7 Signs and Why it's Tough to Do
Closing prices for crude oil, gold and other commodities
United Airlines Soars on Earnings Beat
CSX profit drops 10% despite railroad delivering 3% more freight in first quarter

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Apollo Endosurgery, Inc. stock logo
APEN
Apollo Endosurgery
$9.94
$3.49
$10.30
$579.72M2.311.43 million shs1.66 million shs
Motus GI Holdings, Inc. stock logo
MOTS
Motus GI
$0.08
-11.6%
$0.56
$0.07
$23.40
$420K1.3274,851 shs663,410 shs
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
$18.26
-0.9%
$17.64
$14.51
$22.99
$64.68M0.65,807 shs5,689 shs
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$3.25
+1.6%
$3.91
$1.79
$5.38
$52.46M0.9192,052 shs111,702 shs
10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Apollo Endosurgery, Inc. stock logo
APEN
Apollo Endosurgery
0.00%0.00%0.00%0.00%0.00%
Motus GI Holdings, Inc. stock logo
MOTS
Motus GI
-8.98%-82.73%-88.04%-93.03%-99.44%
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
-1.83%+0.61%+6.16%-12.96%+14.84%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
+1.56%-2.99%-9.72%+19.93%-37.74%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Apollo Endosurgery, Inc. stock logo
APEN
Apollo Endosurgery
N/AN/AN/AN/AN/AN/AN/AN/A
Motus GI Holdings, Inc. stock logo
MOTS
Motus GI
1.5049 of 5 stars
3.55.00.00.00.00.00.6
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
N/AN/AN/AN/AN/AN/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
3.0343 of 5 stars
3.55.00.00.02.50.81.3

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Apollo Endosurgery, Inc. stock logo
APEN
Apollo Endosurgery
N/AN/AN/AN/A
Motus GI Holdings, Inc. stock logo
MOTS
Motus GI
3.00
Buy$28.8837,893.42% Upside
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
N/AN/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
3.00
Buy$7.50130.77% Upside

Current Analyst Ratings

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Apollo Endosurgery, Inc. stock logo
APEN
Apollo Endosurgery
$76.86M0.00N/AN/A$0.69 per share0.00
Motus GI Holdings, Inc. stock logo
MOTS
Motus GI
$320K1.19N/AN/A$1.74 per share0.04
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
$46.09M1.39$2.22 per share8.22$8.91 per share2.05
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$24.41M2.18$0.06 per share55.42$2.98 per share1.09

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Apollo Endosurgery, Inc. stock logo
APEN
Apollo Endosurgery
-$39.84M-$1.02N/AN/AN/A-51.84%-89.48%-33.76%N/A
Motus GI Holdings, Inc. stock logo
MOTS
Motus GI
-$12.87M-$28.55N/AN/A-4,033.54%N/A-110.70%5/8/2024 (Estimated)
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
$7.07M$0.7524.35N/A5.59%8.97%5.40%5/2/2024 (Estimated)
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$490K$0.03108.37N/A1.99%1.04%0.93%5/1/2024 (Estimated)

Latest MOTS, PDEX, APEN, and SRTS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/18/2024Q4 2023
Motus GI Holdings, Inc. stock logo
MOTS
Motus GI
N/A-$4.13-$4.13-$3.78N/A$0.06 million
2/8/2024Q2 2024
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
N/A$0.14+$0.14$0.14N/A$12.59 million
2/8/2024Q4 2023
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$0.12$0.26+$0.14$0.26$12.10 million$12.57 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Apollo Endosurgery, Inc. stock logo
APEN
Apollo Endosurgery
N/AN/AN/AN/AN/A
Motus GI Holdings, Inc. stock logo
MOTS
Motus GI
N/AN/AN/AN/AN/A
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
N/AN/AN/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Apollo Endosurgery, Inc. stock logo
APEN
Apollo Endosurgery
1.04
2.35
1.89
Motus GI Holdings, Inc. stock logo
MOTS
Motus GI
0.46
1.76
1.69
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
0.26
3.66
2.16
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/A
11.76
8.23

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Apollo Endosurgery, Inc. stock logo
APEN
Apollo Endosurgery
76.01%
Motus GI Holdings, Inc. stock logo
MOTS
Motus GI
20.06%
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
15.28%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
25.30%

Insider Ownership

CompanyInsider Ownership
Apollo Endosurgery, Inc. stock logo
APEN
Apollo Endosurgery
17.30%
Motus GI Holdings, Inc. stock logo
MOTS
Motus GI
1.57%
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
42.60%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
11.10%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Apollo Endosurgery, Inc. stock logo
APEN
Apollo Endosurgery
20257.97 million47.94 millionNot Optionable
Motus GI Holdings, Inc. stock logo
MOTS
Motus GI
155.03 million4.95 millionNot Optionable
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
1453.51 million2.02 millionNot Optionable
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
3516.39 million14.57 millionOptionable

MOTS, PDEX, APEN, and SRTS Headlines

SourceHeadline
Sensus Healthcare, Inc. (NASDAQ:SRTS) Short Interest UpdateSensus Healthcare, Inc. (NASDAQ:SRTS) Short Interest Update
americanbankingnews.com - April 11 at 5:40 AM
Sensus Healthcare, Inc. (NASDAQ:SRTS) Sees Large Increase in Short InterestSensus Healthcare, Inc. (NASDAQ:SRTS) Sees Large Increase in Short Interest
marketbeat.com - March 28 at 11:58 AM
Sensus Healthcare Inc.Sensus Healthcare Inc.
wsj.com - March 23 at 2:11 AM
Sensus Healthcare to Participate in the 36th Annual Roth ConferenceSensus Healthcare to Participate in the 36th Annual Roth Conference
globenewswire.com - March 14 at 4:05 PM
Sensus Healthcare Launches “Fair Deal Agreement” for its SRT-100 Vision™ at the American Academy of Dermatology Annual MeetingSensus Healthcare Launches “Fair Deal Agreement” for its SRT-100 Vision™ at the American Academy of Dermatology Annual Meeting
globenewswire.com - March 13 at 8:00 AM
A Market With a HangoverA Market With a Hangover
realmoney.thestreet.com - March 11 at 1:19 PM
3 Stocks to Buy That Are Up 100% or More in 20243 Stocks to Buy That Are Up 100% or More in 2024
investorplace.com - February 25 at 2:02 PM
Sensus Healthcare (SRTS) Price Target Increased by 24.07% to 6.83Sensus Healthcare (SRTS) Price Target Increased by 24.07% to 6.83
msn.com - February 24 at 4:42 AM
Sensus Healthcare Stock (NASDAQ:SRTS) Earnings Dates and Earning CallsSensus Healthcare Stock (NASDAQ:SRTS) Earnings Dates and Earning Calls
benzinga.com - February 23 at 5:28 PM
My Current Game Plan Includes Adding This Small-Cap Stock to My Watch ListMy Current Game Plan Includes Adding This Small-Cap Stock to My Watch List
realmoney.thestreet.com - February 21 at 8:19 PM
Integer Holdings Corporation (ITGR) Soars to 52-Week High, Time to Cash Out?Integer Holdings Corporation (ITGR) Soars to 52-Week High, Time to Cash Out?
finance.yahoo.com - February 12 at 12:53 PM
Sensus Healthcare, Inc. Beat Analyst Profit Forecasts, And Analysts Have New EstimatesSensus Healthcare, Inc. Beat Analyst Profit Forecasts, And Analysts Have New Estimates
finance.yahoo.com - February 11 at 10:42 AM
Sensus Healthcare: Strong Q4 Performance and Promising Future Drive Buy RatingSensus Healthcare: Strong Q4 Performance and Promising Future Drive Buy Rating
markets.businessinsider.com - February 10 at 3:48 PM
Sensus Healthcare, Inc. (SRTS) Q4 2023 Earnings Call TranscriptSensus Healthcare, Inc. (SRTS) Q4 2023 Earnings Call Transcript
seekingalpha.com - February 9 at 7:12 PM
Sensus Healthcare, Inc. (NASDAQ:SRTS) Q4 2023 Earnings Call TranscriptSensus Healthcare, Inc. (NASDAQ:SRTS) Q4 2023 Earnings Call Transcript
finance.yahoo.com - February 9 at 2:11 PM
Q4 2023 Sensus Healthcare Inc Earnings CallQ4 2023 Sensus Healthcare Inc Earnings Call
finance.yahoo.com - February 9 at 9:10 AM
Sensus Healthcare Reports Fourth Quarter and Full Year 2023 Financial ResultsSensus Healthcare Reports Fourth Quarter and Full Year 2023 Financial Results
markets.businessinsider.com - February 8 at 7:56 PM
Sensus Healthcare announces U.S. patent for SRT-100 Vision SystemSensus Healthcare announces U.S. patent for SRT-100 Vision System
msn.com - February 8 at 9:55 AM
Sensus Healthcare Issued U.S. Patent for SRT-100 Vision® System (IG-SRT) CapabilitiesSensus Healthcare Issued U.S. Patent for SRT-100 Vision® System (IG-SRT) Capabilities
finance.yahoo.com - February 8 at 9:55 AM
Earnings Preview For Sensus HealthcareEarnings Preview For Sensus Healthcare
benzinga.com - February 7 at 3:46 PM
Sensus Healthcare Collaborates with CureRays to Provide Oversight to Help Customers Assure Patient Safety, Reliability of Outcomes and Conformance with Regulatory RequirementsSensus Healthcare Collaborates with CureRays to Provide Oversight to Help Customers Assure Patient Safety, Reliability of Outcomes and Conformance with Regulatory Requirements
finance.yahoo.com - February 6 at 1:04 PM
Sensus Healthcare Announces Director Samuel O’Rear’s RetirementSensus Healthcare Announces Director Samuel O’Rear’s Retirement
msn.com - February 3 at 9:40 AM
Apple, Amazon and Meta Will Tell Us a Lot About This Markets HealthApple, Amazon and Meta Will Tell Us a Lot About This Market's Health
realmoney.thestreet.com - February 2 at 12:48 AM
Inogen (INGN) Surges 12.3%: Is This an Indication of Further Gains?Inogen (INGN) Surges 12.3%: Is This an Indication of Further Gains?
finance.yahoo.com - February 1 at 9:38 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Apollo Endosurgery logo

Apollo Endosurgery

NASDAQ:APEN
Apollo Endosurgery, Inc. is a medical technology company, which focuses on the design, development, and commercialization of medical devices to advance gastrointestinal therapeutic endoscopy. It offers Endoscopy, Surgical and Other products. The firm's endoscopy product portfolio consists of the OverStitch Endoscopic Suturing System, the OverStitch Sx Endoscopic Suturing System, and the Orbera Intragastric Balloon System. Its products are used by gastroenterologists and bariatric surgeons in a variety of settings to treat multiple gastrointestinal conditions including closure of acute perforations and chronic fistulas, inadvertent perforation of the GI tract, tissue closure after the removal of abnormal lesions in the esophagus, stomach or colon, the treatment of swallowing disorders, esophageal stent fixation, and obesity. The company was founded by Christopher J. Gostout and Dennis L. McWilliams in 2005 and is headquartered in Austin, TX.
Motus GI logo

Motus GI

NASDAQ:MOTS
Motus GI Holdings, Inc. operates as a medical technology company in the United States. It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedures. The company was formerly known as Eight-Ten Merger Corp. and changed its name to Motus GI Holdings, Inc. in November 2016. Motus GI Holdings, Inc. was founded in 2008 and is based in Fort Lauderdale, Florida.
Pro-Dex logo

Pro-Dex

NASDAQ:PDEX
Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.
Sensus Healthcare logo

Sensus Healthcare

NASDAQ:SRTS
Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.